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Background. Incidental findings on coronary computed tomography angiography (CCTA) have a great impact on the benefits 
and costs of testing for cardiovascular disease. The number of incidental findings might be increased in human immunodeficiency 
virus (HIV)-positive individuals compared with the general population. Data are limited regarding the association between inciden-
tal findings and HIV infection.
Methods. We assessed the prevalence and factors associated with incidental findings among HIV-positive and HIV-negative 
participants ≥45 years undergoing CCTA. Logistic regression was performed to evaluate the factors associated with incidental find-
ings in the HIV-positive and HIV-negative groups. For the analysis of the HIV effect, a propensity score-matched dataset of HIV-
positive/HIV-negative participants was used.
Results. We included 553 participants, 341 with and 212 without HIV infection. Incidental findings were observed in 291 of 553 
(53%) patients. In 42 of 553 (7.6%) participants, an incidental finding resulted in additional workup. A malignancy was diagnosed in 
2 persons. In the HIV-positive group, age (1.31 per 5 years, 1.10–1.56) and smoking (2.29, 1.43–3.70) were associated with inciden-
tal findings; in the HIV-negative group, age (1.26, 1.01–1.59) and a CAC score >0 (2.08, 1.09–4.02) were associated with incidental 
findings. Human immunodeficiency virus seropositivity did not affect the risk of incidental findings.
Conclusions. Incidental findings were highly prevalent among HIV-positive and HIV-negative persons. Human immunodefi-
ciency virus infection was not associated with an increased risk of incidental findings.
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Because coronary computed tomography angiography (CCTA) 
is an increasingly used imaging modality for early detection of 
subclinical atherosclerosis in human immunodeficiency virus 
(HIV)-positive individuals, it is of substantial importance to 
have reliable data on the prevalence of incidental findings dur-
ing CCTA imaging, their clinical significance, and associated 
factors.
Incidental findings have a great impact on the cost effective-
ness of imaging procedures such as the CCTA and might lead 
to changes in clinical management. Moreover, the emotional 
impact on patients by worry regarding malignancy should be 
taken into account.
Persons who are HIV-positive may be at increased risk of 
age-related diseases including nonacquired immune deficiency 
syndrome-associated cancers, osteoporotic fractures, myo-
cardial infarction, and chronic kidney and liver disease com-
pared with the general population of the same age [1]. Human 
immunodeficiency virus-induced chronic immune activation, 
persistent low-grade inflammation, and lifestyle-related factors, 
including a high prevalence of nicotine consumption [2, 3], 
are discussed as contributors. Thus, the number of incidental 
findings noted on cardiac computed tomography (CT) might 
be increased in HIV-positive individuals compared with the 
general population.
Several studies have assessed the frequency and types of inci-
dental findings among the general population during CCTA 
and other imaging modalities [4–10]. Although a few stud-
ies investigated the prevalence of incidental findings in HIV-
positive cohorts [11–13], no study has been performed to date 
comparing incidental findings on CCTA in an HIV-positive 
with an HIV-negative population.
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Therefore, the purpose of this study was to (1) describe the 
prevalence and types of incidental findings among HIV-positive 
and HIV-negative study participants, (2) explore the association 
with demographic and clinical factors, including HIV infection, 
and (3) determine the parameters that are associated with the 
occurrence of incidental findings in the HIV-positive group.
METHODS
Study Design and Study Participants
In this substudy, we evaluated 553 persons with and without 
HIV infection participating in a CCTA study, investigating 
the prevalence of subclinical coronary artery disease (CAD) 
using CCTA and noncontrast CT scan for coronary artery cal-
cification (CAC) scoring. Participants were enrolled between 
October 2013 and July 2016 at the University Hospital Zurich, 
Switzerland. The inclusion criteria were age ≥45 years, no doc-
umented CAD or stroke, glomerular filtration rate ≥60  mL/
minute, no allergy to iodinated contrast agent, and no irreg-
ular heartbeat. All HIV-positive persons were participants of 
the Swiss HIV Cohort Study (SHCS). The HIV-uninfected par-
ticipants were referred for CCTA to the University Hospital of 
Zurich during the enrollment period. By periodical comparisons 
of the 2 groups with regard to age, gender, and Framingham risk 
score and adjusting the selection criteria for the HIV-negative 
individuals, we attempted to include comparable populations.
Data Collection
For HIV-positive participants, clinical and laboratory data 
were collected within the SHCS. In this ongoing, prospective 
cohort study, demographic, clinical, and laboratory data are 
collected at registration and every 6  months thereafter using 
a standard protocol including detailed information on CAD 
events, arterial hypertension, diabetes mellitus, nicotine, alco-
hol, intravenous drug use (IDU), and medication [14]. For 
HIV-negative participants, clinical information was obtained 
using a structured questionnaire that included comorbidities, 
smoking, alcohol, drug use, and current medication. The data 
on the clinical workup and treatment of incidental findings 
were assessed retrospectively by reviewing the clinical charts 
of the CCTA study participants. The protocol was approved by 
the local ethical review board (Kantonale Ethik-Kommission 
Zürich, BASEC-Nr. 2016-01004). Written informed consent 
was obtained from all participants.
Computed Tomography Acquisition and Image Analysis
All CCTA/CAC imaging studies were performed at the 
University Hospital Zurich. Computed tomography contrast 
imaging was completed using a 64-slice Discovery 750 HD or 
256-slice Revolution CT scanner (both from GE Healthcare, 
Waukesha, WI) with a prospectively electrocardiography-trig-
gered cardiac acquisition protocol (SnapShot Pulse, GE) with 
tube voltage (80–120 kVp) and current (115–640 mA) adapted 
to body mass index (BMI). Imaging was done at a temporal 
resolution of 83 to 175 msec with either a step-and-shoot scan 
mode (64-slice scanner) or a single-beat-acquisition mode 
(256-slice scanner). Slice thickness was 0.625  mm. A  BMI-
adapted contrast protocol (Visipaque 320, GE Healthcare) was 
applied (25–105 mL at 3.5–5.0 mL/second). To ensure optimal 
interpretability of the coronary arteries, all patients received 
2.5 mg of sublingual isosorbide dinitrate, and, if needed, up to 
30 mg of metoprolol was injected intravenously to reach a target 
heart rate of <65 beats/minute. The field of view was set to cover 
the entire heart and included, at least partially, the mediasti-
num, aorta, lungs, pleura, lung hila, diaphragm, spine and ribs, 
liver, spleen, adrenal glands, and colon. The cardiac findings 
were assessed by 2 experienced readers of the Cardiac Imaging 
Division, and the incidental extracardiac findings were assessed 
by a board-certified radiologist at the University Hospital 
Zurich in addition.
Definitions
Findings were defined as incidental if not previously known. 
A  finding was deemed to be significant if medical referral or 
radiological workup was recommended. The radiologist’s 
assessment regarding the need for additional workup was 
determined by evidence-based criteria according to current 
radiology guidelines as described previously [4–6]. Pulmonary 
nodules were rated as relevant according to the Fleischner 
Society Guidelines [15]. Arterial hypertension was defined as 
systolic or diastolic blood pressure ≥40 mmHg/≥90 mmHg or 
use of antihypertensive medication. Diabetes was diagnosed in 
participants with plasma glucose levels of >7.0 mmol/L (fasting) 
and >11.1 mmol/L (nonfasting) or receiving antidiabetic med-
ication. Data on alcohol consumption were collected by using 
the alcohol screening test, Alcohol Use Disorders Identification 
Test-Consumption (AUDIT-C) [16].
Statistical Analysis
Patients’ characteristics between the groups of patients with 
and without incidental findings were compared using the P val-
ues from the Fisher’s exact test and Wilcoxon rank-sum test. 
Characteristics with a P value  <.05 were included in a multi-
variate logistic regression model along with other clinically and 
epidemiologically relevant factors and confounders. To identify 
the risk factors associated with incidental findings in the HIV-
positive and HIV-negative population, multivariable regres-
sions were performed in the 2 groups separately. To finally 
assess the role of HIV infection as an effect modifier, an analysis 
in the entire population (including both HIV-positive and HIV-
negative individuals) with HIV status included in interaction 
terms was performed. To assess the association between HIV 
infection and incidental findings, 1:1 propensity score matching 
between cases and controls was carried out. Age, gender, coron-
ary calcification, hypertension, current smoking, alcohol con-
sumption, and BMI were used as predictors for the propensity 
score. The matching resulted in a homogeneous (with respect 
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to the baseline characteristics [see Supplementary Table  3]) 
dataset consisting of 151 cases and 151 controls. A conditional 
logistic regression with HIV infection as covariate was fitted 
to the matched dataset to estimate the effect of HIV infection 
on incidental findings. The HIV-specific determinants of inci-
dental findings in the HIV-infected population were identified 
similarly as outlined above and examined with multivariate 
logistic regression on all HIV-positive individuals. Patients with 
missing information on risk factors were not included in the 
model fitting. The analyses were performed in R (using stats, 
matching, and survival packages).
RESULTS
Study Population
A total of 553 persons, 341 with and 212 without HIV infection, 
were included. Their characteristics at time of cardiac imaging 
are shown in Table 1.
Among the HIV-positive participants (median age 52 years, 
88% men, men who have sex with men 64%, IDU 9.4%), 35% 
were current smokers, and 55% had a CAC score >0. Their 
median duration of HIV infection was 15 years, median CD4 
cell count at the time of CCTA was 603 cells/µL, and 93% were 
on antiretroviral therapy (ART) with suppressed viral load in 
95%. Human immunodeficiency virus-positive individuals 
with incidental findings were older, more likely to be current 
smokers, with a higher Framingham risk score, and had a longer 
duration of HIV infection and years on ART (Supplementary 
Table 1).
The HIV-negative control group (median age 56 years, 77% 
men) consisted of 15% smokers; they had hypertension in 
61% and a CAC score >0 in 61%. Human immunodeficiency 
virus-negative controls with incidental findings compared with 
those without incidental findings were older, more likely to have 
hypertension, a CAC score >0, and a higher Framingham risk 
score (Supplementary Table 2).
Prevalence of Incidental Findings
In 291 of 553 (53%) of all participants, an incidental finding 
was noted. In 116 persons, more than 1 incidental finding was 
found. Overall, 452 incidental findings were detected; they were 
most often in the lungs, followed by bone and the abdomen 
(Table 2).
In the HIV-positive group, in 164 of 341 (48%) participants, 
unexpected findings were diagnosed, most commonly in the 
lungs (59% of all incidental findings), consisting mostly of non-
calcified and calcified nodules, emphysema, atelectasis, and 
scarring. In the HIV-negative comparison group, in 127 of 212 
(60%) patients, incidental findings were detected (48% pulmo-
nary, 23% abdominal, 20% bone abnormalities).
In 42 of 553 (8%) of all participants, an incidental finding 
was rated as clinically relevant requiring follow-up or medical 
Table 1. Baseline Characteristics of Human Immunodeficiency Virus (HIV)-Positive and HIV-Negative Participants
All Patients All Patients
HIV Status
Negative Positive P Value
Total number of patients, n (%) 553 212 (38%) 341 (62%)
Sex, n (%) <.001
 Male 463 (84%) 163 (77%) 300 (88%)
Age [years], median (IQR) 54 (50–60) 56 (51–62) 52 (49–57) <.001
Body mass index [kg/m2], median (IQR) 25.3 (23.1–28.1) 26.0 (23.7–28.7) 24.9 (22.7–27.8) <.001
Body mass index category, n (%) <.001
 23.5–27 201 (36%) 76 (36%) 125 (37%)
 ≤23.5 157 (28%) 42 (20%) 115 (34%)
 ≥27 194 (35%) 93 (44%) 101 (30%)
Diabetes mellitus, n (%) .220
 Yes 26 (4.7%) 13 (6.1%) 13 (3.8%)
Arterial hypertension, n (%) <.001
 Yes 243 (44%) 130 (61%) 113 (33%)
Current smoking, n (%) <.001
 Yes 150 (27%) 32 (15%) 118 (35%)
Active intravenous drug use, n (%) .016
 Yes 10 (1.8%) 0 (0.00%) 10 (2.9%)
Alcohol consumption, n (%) .011
 None/mild 415 (75%) 140 (66%) 275 (81%)
 Moderate 106 (19%) 50 (24%) 56 (16%)
 Severe 4 (0.72%) 0 (0.00%) 4 (1.2%)
CAC score > 0, n (%) .129
 Yes 317 (57%) 129 (61%) 188 (55%)
Framingham CHD score, median (IQR) 9.4 (5.7–14.2) 9.3 (5.7–13.8) 9.4 (5.7–14.4) .815
Abbreviations: CAC, coronary artery calcification; CHD, coronary heart disease; IQR, interquartile range.
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referral. In the HIV-positive group, 30 of 341 (9%) patients 
had clinically relevant incidental findings; in the HIV-negative 
group, 22 of 212 (10%) patients had clinically relevant inciden-
tal findings (Table 3). Investigations revealed a malignancy in 2 
HIV-positive participants, including a lymphoma and pancre-
atic cancer with pulmonary metastases. In a third HIV-positive 
patient, the detection of a suspicious pulmonary nodule resulted 
in a wedge resection. Histology revealed no malignancy but an 
aspergilloma.
Associations Between Clinical Variables and Incidental Findings in 
Human Immunodeficiency Virus (HIV)-Positive and HIV-Negative Persons
Univariable and multivariable analyses of factors contribut-
ing to incidental findings are shown in Figure 1. In the HIV-
positive group, age (odds ratio [OR],  1.31 per 5  years; 95% 
confidence interval [CI], 1.10–1.56) and smoking (OR,  2.29; 
95% CI, 1.43–3.70) were significantly associated with inciden-
tal findings, whereas in the HIV-negative group, age (OR, 1.26 
per 5 years; 95% CI, 1.01–1.59) and a CAC score >0 (OR, 2.08; 
95% CI, 1.09–4.02) were associated with incidental findings 
(Figure  1). In a propensity score-matched dataset of HIV-
positive and HIV-negative participants, HIV seropositivity did 
not increase the prevalence of incidental findings (Figure 2). 
These findings were additionally confirmed in a multivari-
able logistic regression model, where interactions between 
HIV serostatus and risk factors were included (Supplementary 
Figure 1).
Table 2. Number and Type of Incidental Findings on Coronary Computer 
Tomography Scans of 341 Human Immunodeficiency Virus (HIV)-Positive 
and 212 HIV-Negative Participants 
HIV Status
Negative Positive
Location of Incidental Findings (n = 212) (n = 341) Total
Lung 99 (48%) 145 (59%) 244 (54%)
 Parenchymal/ Bronchi 96 140 236
  Nodules >10 mm 1 5 6
  Calcified nodules <10 mm 11 12 23
  Noncalcified nodules <10 mm 44 39 83
  Pneumonia 0 1 1
  Scarring 1 10 11
  Emphysema 4 25 29
  Atelectasis 17 25 42
  Bronchiectasis 2 2 4
  Parenchymal opacity/Consolidation 9 8 17
  Bronchitis/Bronchial thickening 0 4 4
  Cysts 1 4 5
  Bullae 6 5 11
 Pleura 3 5 8
  Thickening 1 2 3
  Effusion 0 1 1
  Calcification 2 1 3
  Retraction hemithorax 0 1 1
Diaphragm 3 (1%) 4 (2%) 7 (2%)
 Diaphragmatic hernia 3 1 4
 Diaphragmatic elevation 0 3 3
Cardiac 2 (1%) 4 (2%) 6 (1%)
 Persistent foramen ovale 1 3 4
 Atrial septal defect 1 1 2
Mediastinum 14 (7%) 18 (7%) 32 (7%)
 Lymph nodes 9 5 14
 Aortic ectasia/aneurysm 4 12 16
 Thymus mass 1 1 2
Abdomen 47 (23%) 33 (13%) 80 (18%)
 Liver 33 21 54
  Gall bladder stone 0 2 2
  Calcification 4 1 5
  Steatosis 7 2 9
  Hypodense lesion 22 16 38
 Spleen 2 5 7
  Calcification 1 0 1
  Accessory spleen 1 3 4
  Splenomegaly 0 2 2
 Adrenal tumor/calcification 1 2 3
 Oesophagus hernia 10 5 15
 Others: Chilaidity-Syndrome 1 0 1
Breasts 0 0 0
Bone, soft tissue 40 (20%) 43 (17%) 83 (18%)
 Rib fracture (healed) 5 6 11
 Scoliosis 0 1 1
 Spondylosis 30 25 55
 Schmorl’s nodes 4 4 8
 Osteochondrosis 1 1 2
 Morbus Forestier 0 1 1
 Vertebral hemangioma 0 3 3
 Lipoma 0 2 2
Total incidental findings 205 (100%) 247 (100%) 452 (100%)
The numbers correspond to the number of incidental findings.
Table 3. Number and Type of Clinically Relevant Incidental Findings on 
Coronary Computer Tomography Scans of 341 Human Immunodeficiency 
Virus (HIV)-Positive and 212 HIV-Negative Participants 
HIV Status
Negative Positive
(n = 212) (n = 341) Total
Lung 15 (68%) 18 (60%) 33 (64%)
 Parenchymal/Bronchi 15 18 33
  Noncalcified nodules <10 mm 10 10 20
  Nodules >10 mm 0 5 5
  Calcified nodules <10 mm 2 0 2
  Emphysema 1 1 2
  Parenchymal opacity/Consolidation 2 0 2
  Scarring 0 1 1
  Bullae 0 1 1
Mediastinum 2 (9.1%) 7 (23%) 9 (17%)
 Lymph nodes 1 1 2
 Aortic ectasia/aneurysm 1 6 7
Abdomen 5 (23%) 4 (13%) 9 (17%)
 Liver 5 4 9
  Hypodense lesion 4 3 7
  Calcification 1 0 1
  Steatosis 0 1 1
Bone, soft tissue 0 (0.0%) 1 (3.3%) 1 (1.9%)
 M Forestier 0 1 1
Total clinically relevant findings 22 (100%) 30 (100%) 52 (100%)
The numbers correspond to the number of incidental findings.
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Likewise, in the same propensity score-matched dataset, 
there was no evidence for higher prevalence of clinically rel-
evant findings among HIV-infected individuals (10 of 151 
[6.6%] in the HIV-positive population vs 13 of 151 [8.6%] in 
the matched HIV-negative population; P = .514).
Associations Between Human Immunodeficiency Virus-Related Variables 
and Incidental Findings
In an analysis restricted to the HIV-positive participants, add-
itionally  years on ART (OR,  1.28 per 5  years; 95% CI, 1.01–
1.64) was associated with incidental findings. CD4 nadir did 
not exhibit a significant effect on incidental findings (OR, 1.09 
per 100 cells/µL; 95% CI, 0.92–1.30), and neither did years of 
untreated HIV infection (OR, 1.11 per 5 years; 95% CI, 0.90–
1.38) (Figure 3).
DISCUSSION
To our knowledge, this is the largest study investigating the 
prevalence of incidental findings in HIV-positive and HIV-
negative persons undergoing CT imaging for assessment of 
subclinical coronary atherosclerosis. In more than half of 553 
patients, we recorded incidental findings with 8 percent of par-
ticipants having clinically relevant findings requiring further 
investigations or treatment. More importantly, HIV infection 
was not associated with the detection of incidental findings.
In the general population, the prevalence of incidental 
findings in CT scans performed for CAC score or CCTA was 
reported to be 13%–53% (reviewed in [9]). In our HIV-positive 
Age (per 5 years)
Female gender
Current smoking
Hypertension
BMI ≤ 23.5 kg/m2
BMI ≥ 27 kg/m2
CAC score > 0
0.5 1 2 4 0.5 1 2 4
OR with 95%-confidence intervals
Incidental findings
HIV-positive persons
Univariable OR Multivariable OR
HIV-negative persons
Figure 1. Associations between demographic and clinical variables and incidental findings stratified for human immunodeficiency virus (HIV) status. The multivariate 
logistic regression analyses including all covariates listed on the left side were carried out separately for all 341 HIV-positive persons with 247 incidental findings (left panel) 
and all 212 HIV-negative persons with 205 incidental findings (right panel). BMI, body mass index; CAC, coronary artery calcification; OR, odds ratio.
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Figure 2. The 1:1 case-control propensity score matching. The propensity scores 
were calculated based on age, gender, coronary artery calcification score >0, hyper-
tension, current smoking, moderate/severe alcohol abuse, and body mass index. The 
proportion of human immunodeficiency virus (HIV)-negative persons in the matched 
dataset is shown in blue and the HIV-positive persons are shown in red. The brighter 
colors represent the patients in the matched dataset without incidental findings, 
and the darker colors represent the patients with incidental findings. The P value 
corresponds to the association between incidental findings and HIV infection from 
the conditional logistic regression with matched HIV positive-HIV negative pairs.
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group, we found a prevalence of 48%. Data among HIV-
positive individuals undergoing cardiac imaging is limited. In 
2 other HIV cohorts, incidental findings on CCTA were inves-
tigated with recorded prevalence of 43% and 57% [11, 12]. In 
both studies, patients were substantially younger (median age 
43  years and 46  years, respectively) compared with our HIV-
positive population (median age 52 years). The study with the 
lower prevalence of CT abnormalities included only 15% cur-
rent smokers [11], whereas in the other study [12] 63% of the 
participants smoked compared with 35% in our study. In add-
ition, other differences of participant characteristics, including 
demographics and alcohol and drug use, might explain the var-
iation in prevalence of unexpected findings [11, 12, 17].
In our HIV-negative comparison group, incidental find-
ings were detected more often (60%) compared with the HIV-
positive group (48%). The HIV-negative participants were 
slightly older, more often had hypertension and a positive CAC 
score, and were referred for cardiac imaging because of clinical 
symptoms, in contrast to our asymptomatic HIV-positive par-
ticipants. To overcome the effect of heterogeneity, we compared 
the HIV-positive group with a propensity score-matched HIV-
negative control group. Thereby, we showed that HIV infection 
had no significant impact on the prevalence of unexpected find-
ings. Because HIV-positive patients are regularly seen by clini-
cians (in the SHCS every 3 to 6  months), the chance to have 
diagnostic procedures with the detection of findings may be 
higher than in the age-matched general population without reg-
ular medical visits. We believe that this is an important reason 
that, in our study, the prevalence of incidental (not yet detected) 
findings was lower in the HIV-positive group than in the HIV-
negative group. Our results are in line with results from the 
Examinations of HIV Associated Lung Emphysema (EXHALE) 
Study in which HIV infection was not associated with abnormal 
findings on chest CT for lung cancer screening in asymptom-
atic participants with CD4 cell counts >200 cells/µL [18]. This 
indicates that although HIV-infected individuals are presumed 
to be affected by chronic inflammation and an increased risk of 
age-related disease, there is no excess risk of incidental findings 
on CCTA.
Increasing age was a strong predictor for incidental findings 
in both of our groups, in accordance with previous studies of 
the general and HIV-infected population [9, 11–13]. Smoking 
was an independent risk factor only in HIV-positive individu-
als. This might be due to the fact that pulmonary findings, par-
ticularly emphysema, were more frequent in the HIV-positive 
compared with HIV-negative patients. A positive CAC score was 
associated with incidental findings in HIV-negative participants; 
similar risk factors for both conditions, not assessed in the analy-
ses, might explain this association, as shown by others [11].
Years on ART, probably a surrogate marker for HIV dur-
ation, was predictive for an increased risk of incidental findings 
among the HIV-positive group (HIV duration was not included 
in the multivariable model because of being collinear with time 
on ART and time off ART). A longer duration of HIV infection 
might be associated with a greater risk of previous pulmonary 
infections resulting in pulmonary nodules, scarring, and atel-
ectasis. Moreover, cumulative antiretroviral toxicity might have 
contributed, but this remains speculative. In our study, a lower 
CD4 cell nadir was not associated with incidental findings, in 
contrast to Park et al [12].
The strengths of our study include the use of a large number 
of HIV-positive and HIV-negative participants including indi-
viduals of both genders. We were able to compare incidental 
findings on CCTA between HIV-positive and a well matched 
HIV-negative group. Our study has potential limitations. The 
2 groups were heterogeneous in terms of demographic and 
clinical characteristics. Therefore, we used a propensity score-
matched comparison cohort for the analysis of the HIV effect 
to minimize potential confounding. Our results might not be 
applicable to other HIV populations because most of our partic-
ipants were in relatively good health, with a low rate of alcohol 
and drug use, on ART, virally suppressed, and received regular 
medical consultations in the setting of a well established obser-
vational study, the SHCS.
CONCLUSIONS
In conclusion, we showed that CCTA, a promising imaging 
tool to diagnose subclinical atherosclerosis in patients with 
increased cardiovascular risk including HIV infection, was 
associated with a remarkable rate of incidental findings. These 
Years on ART
(per 5 years)
Nadir CD4
(per 100) cells/mcL
Years untreated
(per 5 years)
0.5 1
OR with 95%-confidence intervals
Incidental findings
HIV-positive persons - detailed
Univariable OR
Multivariable OR
2 4
Figure  3. Associations between human immunodeficiency virus (HIV)-specific 
variables and incidental findings. Analyses are based on 247 incidental findings in 
341 HIV-positive persons. The results from the multivariable analysis are adjusted 
for the variables listed on the left side in addition to age, gender, current smoking, 
hypertension, body mass index, and coronary artery calcification score >0. ART, anti-
retroviral therapy; OR, odds ratio.
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included clinically significant findings that had implications 
for patient care and were associated with significant additional 
expenses. However, HIV infection was not associated with an 
increased risk of incidental findings.
Supplementary Data
Supplementary materials are available at Open Forum Infectious Diseases 
online. Consisting of data provided by the authors to benefit the reader, 
the posted materials are not copyedited and are the sole responsibility of 
the authors, so questions or comments should be addressed to the corre-
sponding author.
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